New Jersey Assembly Bill ACR186

New Jersey 2022-2023 Regular Session

• Introduced: 11/30/23
• Refer: 11/30/23

Caption

Urges Governor to direct all relevant State departments and agencies to help decrease number of fatalities caused by atherosclerotic cardiovascular disease.

Impact

If enacted, ACR186 would prompt a review and update of existing health policies specifically targeting atherosclerotic cardiovascular disease. The resolution stresses the importance of lowering levels of low-density lipoprotein cholesterol (LDL-C), a major contributor to cardiovascular issues, suggesting that a significant number of adults are struggling to manage their cholesterol effectively. By advocating for improved cardiovascular health screening measures and enhanced quality of care, the bill seeks to pave the way toward better health outcomes for those affected by ASCVD, particularly in New Jersey where substantial financial resources are devoted to treating associated health conditions.

Summary

Assembly Concurrent Resolution No. 186, introduced in New Jersey, urges the Governor to direct all relevant state departments and agencies to take action in reducing fatalities caused by atherosclerotic cardiovascular disease (ASCVD). This resolution highlights cardiovascular disease as a leading cause of death in the United States, supported by alarming statistics that indicate over 21 million Americans are diagnosed with ASCVD, with a significant proportion at risk of serious cardiovascular events. The bill calls for enhanced measures to manage this pervasive health issue, reinforcing the urgent need for state intervention and collaboration across health departments.

Contention

While the bill is intended to promote public health and potentially reduce the burden of ASCVD, there may be concerns regarding the adequacy of funding and resources allocated to implement the proposed screenings and policy updates. Stakeholders may argue about the efficacy of policy changes without the necessary financial backing, and the overall coordination between state and federal agencies might also present challenges. The resolution aims to encourage cross-agency collaboration but achieving effective communication and consistent strategies could pose an ongoing consideration in the efforts to combat ASCVD.